Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Matched Paired Pharmacodynamics and Feasibility Study of Durvalumab in Combination With Chemotherapy in Frontline Ovarian Cancer (N-Dur)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT02726997
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:28:47.315728+00:00
Published At
2025-12-18T00:00:00+00:00
Record Updated At
2025-12-18
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Stage III Fallopian Tube Cancer AJCC v7", "Stage III Ovarian Cancer AJCC v6 and v7", "Stage III Primary Peritoneal Cancer AJCC v7", "Stage IIIA Fallopian Tube Cancer AJCC v7", "Stage IIIA Ovarian Cancer AJCC v6 and v7", "Stage IIIA Primary Peritoneal Cancer AJCC v7", "Stage IIIB Fallopian Tube Cancer AJCC v7", "Stage IIIB Ovarian Cancer AJCC v6 and v7", "Stage IIIB Primary Peritoneal Cancer AJCC v7", "Stage IIIC Fallopian Tube Cancer AJCC v7", "Stage IIIC Ovarian Cancer AJCC v6 and v7", "Stage IIIC Primary Peritoneal Cancer AJCC v7", "Stage IV Fallopian Tube Cancer AJCC v6 and v7", "Stage IV Ovarian Cancer AJCC v6 and v7", "Stage IV Primary Peritoneal Cancer AJCC v7"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2025-12-18"
protocolSection.identificationModule.nctId
"NCT02726997"
protocolSection.identificationModule.officialTitle
"Matched Paired Pharmacodynamics and Feasibility Study of Durvalumab in Combination With Chemotherapy in Frontline Ovarian Cancer (N-Dur)"
protocolSection.statusModule.overallStatus
"ACTIVE_NOT_RECRUITING"
protocolSection.designModule.phases
["PHASE1", "PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Stage III Fallopian Tube Cancer AJCC v7 (protocolSection.conditionsModule.conditions)
  • Stage III Ovarian Cancer AJCC v6 and v7 (protocolSection.conditionsModule.conditions)
  • Stage III Primary Peritoneal Cancer AJCC v7 (protocolSection.conditionsModule.conditions)
  • Stage IIIA Fallopian Tube Cancer AJCC v7 (protocolSection.conditionsModule.conditions)
  • Stage IIIA Ovarian Cancer AJCC v6 and v7 (protocolSection.conditionsModule.conditions)
  • Stage IIIA Primary Peritoneal Cancer AJCC v7 (protocolSection.conditionsModule.conditions)
  • Stage IIIB Fallopian Tube Cancer AJCC v7 (protocolSection.conditionsModule.conditions)
  • Stage IIIB Ovarian Cancer AJCC v6 and v7 (protocolSection.conditionsModule.conditions)
  • Stage IIIB Primary Peritoneal Cancer AJCC v7 (protocolSection.conditionsModule.conditions)
  • Stage IIIC Fallopian Tube Cancer AJCC v7 (protocolSection.conditionsModule.conditions)
  • Stage IIIC Ovarian Cancer AJCC v6 and v7 (protocolSection.conditionsModule.conditions)
  • Stage IIIC Primary Peritoneal Cancer AJCC v7 (protocolSection.conditionsModule.conditions)
  • Stage IV Fallopian Tube Cancer AJCC v6 and v7 (protocolSection.conditionsModule.conditions)
  • Stage IV Ovarian Cancer AJCC v6 and v7 (protocolSection.conditionsModule.conditions)
  • Stage IV Primary Peritoneal Cancer AJCC v7 (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.